Cargando…
Various Clinical Presentations of Uveitis Associated with Durvalumab Treatment
BACKGROUND: Immune checkpoint inhibitors (ICI) are becoming increasingly common in treating several cancer types. Durvalumab is a human IgG1 monoclonal antibody that blocks PD-L1 binding to PD-1 and CD80 and has recently been approved for the treatment of extensive-stage small-cell lung cancer (ES-S...
Autores principales: | Vrabic, Nika, Fakin, Ana, Mekjavic, Polona Jaki, Janzic, Urska, Vrankar, Martina, Valentincic, Natasa Vidovic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122297/ https://www.ncbi.nlm.nih.gov/pubmed/35412706 http://dx.doi.org/10.2478/raon-2022-0007 |
Ejemplares similares
-
Choroidal thickening with serous retinal detachment in BRAF/MEK inhibitor-induced uveitis: A case report
por: Kiraly, Peter, et al.
Publicado: (2022) -
The Comparison of Retinal Microvascular Findings in Acute COVID-19 and 1-Year after Hospital Discharge Assessed with Multimodal Imaging—A Prospective Longitudinal Cohort Study
por: Jevnikar, Kristina, et al.
Publicado: (2023) -
The impact of acute COVID-19 on the retinal microvasculature assessed with multimodal imaging
por: Jevnikar, Kristina, et al.
Publicado: (2022) -
The Role of ACE, ACE2, and AGTR2 Polymorphisms in COVID-19 Severity and the Presence of COVID-19-Related Retinopathy
por: Jevnikar, Kristina, et al.
Publicado: (2022) -
Clinical Features of Acute Anterior Uveitis with Complicated Course in a Slovenian Patient Population
por: Vergot, Katarina, et al.
Publicado: (2020)